Emkay Global gets approval for listing 1,00,000 shares from warrant conversion

1 min read     Updated on 11 Jul 2026, 10:14 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Emkay Global Financial Services has received in-principle approval from NSE and BSE to list 1,00,000 equity shares allotted to promoter Prakash Kacholia upon conversion of warrants. The shares, issued at a premium of ₹229.50 each, are subject to depository confirmations and compliance with SEBI regulations.

powered bylight_fuzz_icon
45242254

*this image is generated using AI for illustrative purposes only.

Emkay Global Financial Services Limited has secured in-principle approval from the National Stock Exchange of India Limited (NSE) and BSE Limited to list 1,00,000 equity shares arising from the conversion of warrants issued on a preferential basis. The approval, granted on July 10, 2026, paves the way for these shares to be admitted to dealings on the exchanges, subject to final confirmations from depositories.

The equity shares, carrying a face value of ₹10 each, were allotted to promoter Prakash Kacholia following the conversion of equivalent warrants. The shares were issued at a premium of ₹229.50 each and bear distinctive numbers ranging from 27130132 to 27230131. The NSE reference number for the approval is NSE/LIST/55789, while the BSE reference number is LOD/PREF/PR/FIP/491/2026-27.

Listing Conditions and Compliance

The exchanges have specified that the shares will be listed and admitted to dealings only upon receipt of confirmation from depositories—NSDL and CDSL—regarding the credit of the beneficiaries' accounts. The company must also ensure compliance with Regulation 167 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations.

In the event of a change exceeding two per cent of the total paid-up share capital, Emkay Global Financial Services is required to file the shareholding pattern in XBRL mode under Regulation 31(1)(c) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of the Allotment

Parameter Details
Number of Equity Shares 1,00,000
Face Value ₹10 each
Issue Price ₹229.50 (Premium)
Allottee Prakash Kacholia (Promoter)
Distinctive Numbers 27130132 to 27230131
NSE Reference NSE/LIST/55789
BSE Reference LOD/PREF/PR/FIP/491/2026-27

The company must apply for trading approval within seven working days from the date of the listing approval, as per Schedule XIX of the ICDR Regulations and a SEBI circular dated June 21, 2023. Failure to comply with this timeline may result in penalties. The final trading approval is contingent upon the submission of listing approval from the other exchange and confirmation letters from the depositories regarding the lock-in of pre-preferential holding, if applicable.

Historical Stock Returns for Emkay Global Financial Services

1 Day5 Days1 Month6 Months1 Year5 Years
+0.89%-0.15%-9.91%-3.48%+2.51%+140.41%

How will the conversion of these warrants impact the promoter's shareholding percentage and future voting power?

What strategic initiatives does Emkay Global plan to fund with the capital raised from this warrant conversion?

Could this move signal a trend of increased promoter confidence in the company's long-term growth prospects?

Emkay Global Financial Services
View Company Insights
View All News
like16
dislike

Emkay Global gets trading approval for 7.93 lakh promoter shares

1 min read     Updated on 20 Jun 2026, 04:19 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Emkay Global Financial Services secured trading approval for 7,93,400 promoter shares converted from warrants, listed on NSE and BSE starting June 19, 2026. Issued at a ₹229.50 premium, the shares face an 18-month lock-in ending in December 2027.

powered bylight_fuzz_icon
43454929

*this image is generated using AI for illustrative purposes only.

emkay global financial services has received trading approval from the National Stock Exchange of India Limited (NSE) and BSE Limited for 7,93,400 equity shares allotted to promoters upon conversion of warrants. The shares were issued on a preferential basis under Chapter V of the Securities and Exchange Board of India (Issue and Capital Disclosure Requirements) Regulations, 2018. The trading approval was granted via letters dated June 18, 2026, and the shares are admitted to dealings on the exchanges from June 19, 2026.

The approvals cover two distinct tranches of shares. The first tranche comprises 3,78,300 equity shares, while the second tranche consists of 4,15,100 equity shares. Both tranches were allotted pursuant to the conversion of warrants issued on a preferential basis. The equity shares have a face value of ₹10 each and were issued at a premium of ₹229.50 per share.

Trading and Lock-in Details

The stock exchanges have confirmed that the shares are listed effective from June 19, 2026. However, in accordance with SEBI ICDR Regulations, these equity shares are subject to a lock-in period. The lock-in duration is set for 18 months from the receipt of the trading approval letters, which were issued on June 18, 2026.

Sr No Number of Shares Distinctive Numbers Range Lock-in End Date
1 3,78,300 26336732 to 26715031 18-Dec-2027
2 4,15,100 26715032 to 27130131 22-Dec-2027
Total 7,93,400

Regulatory Compliance

The intimation was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has disclosed that there is no withdrawal, cancellation, or suspension of the license. The detailed information regarding the approval and lock-in period has been submitted to the exchanges as required under the SEBI Master Circular dated January 30, 2026.

Historical Stock Returns for Emkay Global Financial Services

1 Day5 Days1 Month6 Months1 Year5 Years
+0.89%-0.15%-9.91%-3.48%+2.51%+140.41%

How will the market react to the potential increase in floating supply once the 18-month lock-in period expires in December 2027?

What are the promoters' strategic intentions behind converting these warrants, and does this signal confidence in the company's long-term growth?

How will the infusion of approximately ₹182 crore from the warrant conversion impact Emkay Global's capital allocation and expansion plans?

Emkay Global Financial Services
View Company Insights
View All News
like16
dislike

More News on Emkay Global Financial Services

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+2.51%